Fibrolamellar Carcinoma as a Cause of Bile Duct Obstruction

References

• Craig J R, Peters R I, Edmondson H A, Omata M. Fibrolamellar carcinoma of the liver: a tumour of adolescents and young adults with distinctive clinicopathological features. Cancer 1980; 46: 372–9
   PubMed Web of Science ®Google Scholar
• Berman M M, Libbey N P, Foster J H. Hepatocellular carcinoma. Polygonal cell type with fibrous stroma—an atypical variant with a favourable prognosis. Cancer 1980; 46: 1448–55
   PubMed Web of Science ®Google Scholar
• Lack E E, Neave C, Vawter O F. Hepatocellular carcinoma. Review of 32 cases in childhood and adolescence. Cancer 1983; 52: 1510–5
   PubMed Web of Science ®Google Scholar
• Farhi D C, Shikes R H, Murari P J, Silverberg S G. Hepatocellular carcinoma in young people. Cancer 1983; 52: 1516–25
   PubMed Web of Science ®Google Scholar
• Nagorney D M, Adson M A, Weiland L H, et al. Fibrolamellar hepatoma. Am J Surg 1985; 149: 113–9
   PubMed Web of Science ®Google Scholar
• Ihde D C, Matthews M J, Makuch R W, et al. Prognostic factors in patients with hepatocellular carcinoma receiving systemic chemotherapy. Identification of two groups of patients with prospects for prolonged survival. Am J Med 1985; 78: 399–406
   PubMed Web of Science ®Google Scholar
• Goodman Z D, Ishak K G, Langloss J M, et al. Combined hepatocellular cholangiocarcinoma. A histological and immunohistochemical study. Cancer 1985; 55: 124–35
   PubMed Web of Science ®Google Scholar
• Schmidt D, Harms D, Lang W. Primary malignant hepatic tumours in childhood. Virch Arch (Pathol Anal) 1985; 407: 387–405
   PubMedGoogle Scholar
• Giacomantonio M, Ein S H, Mancer K, Stephens C A. Thirty years of experience with paediatric primary malignant liver tumours. J Paediatr Surg 1984; 19: 523–6
   PubMedGoogle Scholar
• Friedman A C, Lichtenstein J E, Goodman Z D, et al. Fibrolamellar hepatocellular carcinoma. Radiology 1985; 157: 583–7
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Gordon R D, Byers W S, Starzl T E. Role of liver transplantation in cancer therapy. Ann Surg 1985; 202: 401–7
   PubMed Web of Science ®Google Scholar
• Sumithran E. Fibrolamellar carcinoma of the liver. Am J Clin Pathol 1984; 82: 633–4
   PubMedGoogle Scholar
• Edmondson H A, Peters R L. Neoplasms of the liver. Diseases of the liver. 5th ed, L Schiff, E R Schiff. JB Lippincott Company, Philadelphia 1982; 1101–58
   Google Scholar
• Vecchio F M, Fabiano A, Ghirlanda G, et al. Fibrolamellar carcinoma of the liver: the malignant counterpart of focal nodular hyperplasia with oncocytic change. Am J Clin Pathol 1984; 81: 521–6
   PubMed Web of Science ®Google Scholar
• Teitelbaum D H, Tuttle S, Carey L C, Clausen K P. Fibrolamellar carcinoma of the liver. Review of three cases and the presentation of a characteristic set of tumour markers defining this tumour. Ann Surg 1985; 202: 36–41
   PubMedGoogle Scholar
• Collier N A, Weinbren K, Bloom J R, et al. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1984; 538–40
   PubMedGoogle Scholar
• Paradinas F J, Melia W M, Wilkinson M L, et al. High serum vitamin B12 binding capacity as a marker of the fibrolamellar variant of hepatocellular carcinoma. Br Med J 1982; 285: 840–2
   PubMed Web of Science ®Google Scholar
• Phillips J M, Poucell S, Patterson J, Valencia P. Liver tumours and tumour-like conditions. The liver. An atlas and text of ultra-structural pathology. Raven Press, New York 1987; 447–517
   Google Scholar
• Albaugh J S, Keefe E B, Krippaehne W W. Recurrent obstructive jaundice caused by fibrolamellar carcinoma. Dig Dis Sci 1984; 29: 762–7
   PubMedGoogle Scholar
• Harary A M, Raskin J B, Shifrin H D, Vidal J J. Hepatocellular carcinoma presenting as biliary colic and unilateral bile duct obstruction: demonstration ERC. Gastrointest Endosc 1984; 30: 350–2
   PubMedGoogle Scholar
• Eyskens E, Van der Stighelen Y, Bourgeois N. Icterogenic hepatocellular carcinoma and polygonal cell carcinoma with fibrous stroma (fibrolamellar hepatocarcinoma). Acta Chir Belg 1987; 87: 19–25
   PubMedGoogle Scholar
• Caballero T, Aneiros J, Lopez-Caballero J, et al. Fibrolamellar hepatocellular carcinoma. An immunohistochemical and ultra-structural study. Histopathology 1985; 9: 445–56
   PubMedGoogle Scholar
• Lee N W, Wong K P, Siu K F, Wong J. Cholangiography in hepatocellular carcinoma with obstructive jaundice. Clin Radiol 1984; 35: 119–23
   PubMedGoogle Scholar
• Okuda K. Clinical aspects of hepatocellular carcinoma—analysis of 134 cases. Hepatocellular carcinoma, K Okuda, R I Peters. John Wiley and Sons, New York 1976; 387–436
   Google Scholar
• Chuong J JH, Livstone E M, Barwick K W. The histopathologic and clinical indicators of prognosis in hepatoma. Clin Gastroenterol 1982; 4: 547–52
   Google Scholar
• Afroudakis A, Bhuta S M, Ranganath K A, Kaplowitz N. Obstructive jaundice caused by hepatocellular carcinoma. Report of three cases. Am J Dig Dis 1978; 23: 609–17
   PubMedGoogle Scholar
• Ihde D C, Sherlock P, Winawer S J, Fortner J G. Clinical manifestations of hepatoma. A review of 6 years' experience at a cancer hospital. Am J Med 1974; 56: 83–91
   PubMed Web of Science ®Google Scholar
• Carella G, Degott C, Benhamon J P. Invasion of the lumen of the bile ducts by hepatocellular carcinoma. Liver 1981; 1: 251–4
   PubMedGoogle Scholar
• Kojiro M, Kiyoharu K, Kawano Y, et al. Hepatocellular carcinoma presenting as intrabile duct tumour growth. A clinicopathologic study of 24 cases. Cancer 1982; 49: 2144–7
   PubMedGoogle Scholar
• Nonomura A, Ohta G, Kanai M, Kobayashi K. Hepatocellular carcinoma presenting extrahepatic biliary obstruction. Acta Pathol Jpn 1983; 33: 789–806
   PubMedGoogle Scholar
• Cleland P G, Adjukiewicz A. Hepatoma and obstructive jaundice. Postgrad Med J 1980; 56: 371–2
   PubMed Web of Science ®Google Scholar
• Joehl R J, Abt A B. Obstructive jaundice caused by hepatocellular carcinoma. J Surg Oncol 1984; 27: 80–4
   PubMedGoogle Scholar
• Roslyn J J, Kuchenbecker S, Longmire W P, Tompkins R K. Floating tumour debris. A cause of intermittent biliary obstruction. Arch Surg 1984; 119: 1312–5
   PubMedGoogle Scholar
• Moosa M R, Segal I, Mannell A, Hodkinson J H, Paterson A. Bile obstruction in hepatocellular carcinoma—visualisation by endoscopic retrograde cholangiography. A case report. S Afr Med J 1984; 66: 962–4
   PubMedGoogle Scholar
• Stromeyer F W, Ishak K G, Gerber M A, Mathew T. Ground-glass cells in hepatocellular carcinoma. Am J Clin Pathol 1980; 74: 254–8
   PubMed Web of Science ®Google Scholar
• An T, Ghatak N, Kastner R, et al. Hyaline globules and intracellular lumina in a hepatocellular carcinoma. Am J Clin Pathol 1983; 79: 392–6
   PubMed Web of Science ®Google Scholar
• Cooke C, Mooy N, Matz L R, Armstrong J A. Test and teach. Number fifty-three. Pathology 1986; 18: 281–2; 357
   PubMed Web of Science ®Google Scholar
• Mieurau G W, Orsini E N. The Aspen course. Case 1. Ultrastruct Pathol 1983; 5: 273–9
   Google Scholar
• Payne C M, Nagle R B, Paplanus S H, Graham A R. Fibrolamellar carcinoma of liver. A primary malignant oncocytic carcinoid? Ultrastruct Pathol 1986; 10: 539–52
   PubMed Web of Science ®Google Scholar